Hong Kong-listed CXO concept stocks fluctuated lower, with WuXi Biologics falling more than 5%.

Concept stocks in Hong Kong's CXO market are fluctuating and trending lower. BeiGene Biotech dropped more than 5%, GenScript Biotech fell over 3%, while Hutchison China MediTech, WuXi Biologics, Tasly Pharmaceutical, and Zai Lab all fell over 2%.